Marianne Veyri

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Outcomes of Kaposi sarcoma in people living with HIV who maintain long-term viral suppression: A prospective case-series.

Outcomes of Kaposi sarcoma in people living with HIV who maintain long-term viral suppression: A prospective case-series.

Journal: HIV medicine
Published: March 18, 2026

CANCERIMMUNE: A new INCa network designed to strengthen expertise in cancers of immunocompromised patients

CANCERIMMUNE: A new INCa network designed to strengthen expertise in cancers of immunocompromised patients

Journal: Bulletin du cancer
Published: December 04, 2025

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Journal: The oncologist
Published: October 15, 2025

A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and Ozcelik.

A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and Ozcelik.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2025

Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sites.

Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sites.

Journal: Scientific reports
Published: April 23, 2025

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis.

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis.

Journal: Cancer medicine
Published: March 26, 2025

Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.

Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 27, 2024

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Journal: Journal for immunotherapy of cancer
Published: August 06, 2024

The value of anti-CD30 CAR T cells in Hodgkin lymphoma.

The value of anti-CD30 CAR T cells in Hodgkin lymphoma.

Journal: The Lancet. Haematology
Published: March 14, 2024

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.

Journal: Haematologica
Published: September 20, 2023

FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study.

FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study.

Journal: Acta oncologica (Stockholm, Sweden)
Published: June 05, 2023

CD30 as a therapeutic target in adult haematological malignancies: Where are we now?

CD30 as a therapeutic target in adult haematological malignancies: Where are we now?

Journal: British journal of haematology
Published: January 20, 2023
Showing 1-12 of 31

Last Updated: 09/26/2026